CryoLife to Present at 20th Annual Piper Jaffray Health Care Conference
November 24 2008 - 8:00AM
PR Newswire (US)
ATLANTA, Nov. 24 /PRNewswire-FirstCall/ -- CryoLife, Inc.
(NYSE:CRY), a biomaterials, medical device and tissue processing
company, announced today that it is scheduled to participate in the
20th Annual Piper Jaffray Health Care Conference at The New York
Palace Hotel on December 2, 2008. Steven G. Anderson, president and
chief executive officer of CryoLife, Inc., will provide a corporate
overview and host a question and answer session at 2:30 p.m.
Eastern Time. CryoLife's live presentation may be accessed through
its Web site, http://www.cryolife.com/ , on the Investor Relations
page. An archived copy of the presentation will be available for 90
days on the same Web site. About CryoLife Founded in 1984,
CryoLife, Inc. is a leader in the processing and distribution of
implantable living human tissues for use in cardiac and vascular
surgeries throughout the U.S. and Canada. The Company has received
FDA clearance for the CryoValve(R) SG pulmonary human heart valve,
processed using CryoLife's proprietary SynerGraft(R) Technology.
The Company's BioGlue(R) Surgical Adhesive is FDA approved as an
adjunct to sutures and staples for use in adult patients in open
surgical repair of large vessels. BioGlue is also CE marked in the
European Community and approved in Canada and Australia for use in
soft tissue repair. CryoLife distributes Hemostase MPH(R), a
hemostatic agent, in much of the U.S. for use in cardiac and
vascular surgery and in the United Kingdom, Germany, France, and
Canada for cardiac, vascular, and general surgery, subject to
certain exclusions. The Company also distributes the
CryoLife-O'Brien(R) Stentless Porcine Aortic Bioprosthesis, which
is CE marked for distribution within the European Community. For
additional information about the Company, visit CryoLife's Web
Site: http://www.cryolife.com/ . Media Contacts: D. Ashley Lee
Katie Brazel Executive Vice President, Fleishman Hillard Chief
Financial Officer and Phone: 404-739-0150 Chief Operating Officer
Phone: 770-419-3355 DATASOURCE: CryoLife, Inc. Contact: D. Ashley
Lee, Executive Vice President, Chief Financial Officer and Chief
Operating Officer of CryoLife, Inc., +1-770-419-3355; or Katie
Brazel of Fleishman Hillard, for CryoLife, Inc., +1-404-739-0150
Web site: http://www.cryolife.com/
Copyright
CryoLife (NYSE:CRY)
Historical Stock Chart
From Jun 2024 to Jul 2024
CryoLife (NYSE:CRY)
Historical Stock Chart
From Jul 2023 to Jul 2024